| INTRODUCTION
Prostate cancer is now the second most frequently diagnosed cancer worldwide (Lee et al., 2015) . However, in more developed countries, deaths from prostate cancer are decreasing, as a result of improved treatment and better detection (Torre et al., 2015) . Increased survival from, or with, prostate cancer introduces new challenges now being addressed under the umbrella term cancer survivorship, a phase of care concerned with supporting the chronic side effects of cancer treatment (Attard et al., 2016; Colella & Gejerman, 2013) . In this article, we examine the dominance of heteronormative assumptions and invite a more open debate about whether cancer services currently meet the needs of all, rather than the heterosexual majority.
| HETERONORMATIVITY AND PROSTATE CANCER
The incidence of prostate cancer is increasing, and it is inevitable that a proportion of gay and bisexual men will be diagnosed in their lifetime. There is concern that for some of these men, prostate cancer may present particular challenges relating to sexual function (often due to side effects of treatment rather than the cancer itself), but also because of the heteronormative bias in clinical settings (Asencio, Blank, Descartes, & Crawford, 2009) . Some men consider impotence because of treatment as an inevitable or even acceptable side effect, whereas others may associate impotence with their identity as men (Chapple & Ziebland, 2002) . For men who do not identify as heterosexual, there are particular issues to consider. One of the most pertinent is the role that heteronormativity plays in shaping service provision.
Heteronormativity has been defined as "the hegemonic discursive and nondiscursive normative idealisation of heterosexuality" (Hird, 2004, p. 27) . It rests on several assumptions about human sexuality including binary opposites of male/female sexual roles stemming from a heterosexual stance. Thus, medical culture may mirror heteronormative discourses by failing to challenge assumptions about information needs connected with prostate cancer (information usually created by, and directed at, men who identify as heterosexual). Heteronormative assumptions can also be more widely pervasive and influence others such as prostate cancer charities, advocacy organisations or research funders.
Recently (from the 1960s onwards in the United Kingdom), there was a reluctance to view gay men as equal to heterosexual men (Herek, 2000) . Although attitudes are changing, sexual acts between men who have sex with other men remain taboo in some circles (McDonagh, Bishop, Brockjman, & Morrison, 2014) . This may be reflected in clinical practice, particularly through subtle yet powerful reinforcements such as the heteronormative language used in scales to measure quality of life or sexual dysfunction (McDonagh et al., 2014) or during specific communication tasks such as assessment of sexual functioning which reinforce vaginal penetration (Carr, 2007 ).
An example of such an assumption can be seen in the methods for assessment of erectile dysfunction after prostate cancer treatment. It is well documented that the outcomes of such treatments can include problems with sexual functioning, such as erectile dysfunction, penile shrinkage and loss of libido (Asencio et al., 2009; Blank, 2005) , as well as potential damage to the pelvic floor causing urinary and faecal incontinence (often as a result of surgical intervention and radiotherapy). Discussions about sexual dysfunction after prostate cancer treatment commonly focus on the assessment of erectile (dys)function, however, based on the assumption that the "ideal" penis should be erect enough to achieve and maintain vaginal penetration. However, this fails to recognise a group of men for whom vaginal penetration may not be a concern. For sexually active men who have sex with men (MSM), oral or anal penetration may be more concerning when sexual activity is assessed, and for men who are anally receptive, concerns will centre more on the late effects of radiotherapy on bowel or rectal function, including abdominal pain, dietary advice or diarrhoea management (Blank, 2005) .
Since the introduction of Viagra in the late 1990s, conversations about the restoration of erectile function have become part of normative speech in prostate practice (Incrocci, 2011) ; however, conversations about oral sex or anal penetration may remain more taboo in clinical discourse. The difficulty clinicians may face in asking MSM about their sexuality is often reflected in the confidence gay or bisexual men have in the attitudes of healthcare professionals (Blank, 2005) . MSM may feel that they need to tread carefully with heterosexually orientated clinicians, with the associated worry of experiencing subtle or overt homophobia. These fears may, in turn, evoke feelings of isolation and embarrassment that can be implicated in late presentation of cancer symptoms (Jowett & Peel, 2009 What does this paper contribute to the wider global clinical community?
• This paper questions the role that assumptions about sexual orientation can make to men facing a diagnosis of prostate cancer. It uses heteronormativity as a way of understanding the dominant heterosexual assumptions that may exist in cancer services and with cancer professionals. These become especially important in prostate cancer when side effects and related concerns are being discussed. Equity in cancer care must include consideration of diversity in sexual orientation, and we explore the need for this to occur in the context of prostate cancer in this discussion paper.
| THE PROFESSIONAL RESPONSE
In the United Kingdom, the remit of the Clinical Nurse Specialist, Advanced Practitioner or Consultant Nurse roles has expanded greatly over the last 30 years and commonly involves the giving of a prostate cancer diagnosis and ongoing psychosocial support (Tarrant, Sinfield, Agarwal, & Baker, 2008) . One of the reasons for this is that their remit is to support the patient and their family and because of the widespread requirement for each patient with cancer to be assigned a key worker at diagnosis. Confirming a cancer diagnosis can evoke anxiety for the nurse about communicating this life-changing news with sensitivity, but also with authority, so that the patient has confidence and feels secure. This is a skill which takes some time to master, as does a conversation with a patient about sexual dysfunction. There is evidence that such conversations may not always take place-even in consultations involving patients with prostate cancer who have completed treatment for prostate cancer (Forbat, White, Marshall-Lucette, & Kelly, 2012) . In the Forbat et al.
(2012) study, consultations between doctors and patients with prostate cancer were observed. The findings suggested that comparative studies are now needed to establish whether nurses, with the necessary skills and training, are able to address psychosexual concerns more effectively.
However, in clinical situations (which may not always be conducive to communication about intimate concerns), it may surprise or sometimes embarrass men when sex is mentioned during a consultation about their cancer. It is reasonable to suggest that training and experience will be required on the part of the nurse to choose the best time to move the conversation on from initial embarrassment to uncover how MSM feel about their diagnosis, their psychosexual recovery or adjustment to a new reality that may incorporate some degree of sexual dysfunction.
It is also reasonable to assume that most health professionals are not homophobic; rather they may feel that it is safer to discuss erectile dysfunction in the context of vaginal penetration. This may be due to guidelines about onward referral emphasising this in relation to the treatment options being offered.
For the wider cancer care community, there is a need to understanding the wider context for gay and bisexual men and opportunities need to be given to nurses to explore and challenge any preconceptions they may hold. This process could start by involving nurses with the gay and bisexual community to become better informed about diversity, including sexual orientation, so that a conversation can be had at diagnosis about which aspect of treatment is going to affect men the most, and where and when the best support can be offered.
There is evidence of efforts being made to do this by bringing stakeholders together to share experiences and make information available to the MSM community (Prostate Cancer UK & Stonewall, 2013) . Gay professionals themselves have also contributed to this change process by adding their own life experience and views to the literature (Cornell, 2005) .
Gay men are only one of the groups whose intimate sexual lives may be treated with some degree of taboo by health providers.
There are specific issues around prostate cancer for trans women that also require to be addressed and dealt with sensitively, sometimes many years after gender reassignment (The Lancet Oncology, 2015) . Disabled people face similar issues, and it is important to consider the wider impact on these diverse groups in order to compare the nature of heteronormative-based inequality across different contexts.
| WHO IS ALLOWE D TO BE SEXUAL?
Despite recognition of the needs and rights of disabled people and people living with illness to sexuality, many healthcare professionals report reluctance to address sexuality (Esmail, Darry, Walter, & Knupp, 2010) . Much of this reluctance can be traced to social discourses that limit the right to sexuality to an idealised young, heterosexual, able-bodied male and subsequently deny the sexuality of those who do not fit in this model (Tepper, 2000) .
Sexuality relates to how people behave, the choices they make and to who and what they desire (Weeks, 2002) . Sexuality is often considered to be a deeply personal matter, unique to each individual.
Historically, sexual desire has been seen as "natural and automatic and heterosexual and universal" (Gagnon & Parker, 1995, p. 12) , while sex has often been viewed as "a privilege of the white, heterosexual, young, single, non-disabled" (Tepper, 2000, p. 285) people.
The perception of sexuality as a normative construct was problematised and ultimately deconstructed as a result of the social transformations of the 1970s (e.g., the gay rights and feminist movements).
For several years, understandings of disability and illness were influenced by the medical model. According to this model, the causes of illness and disability are located within the biological body (Stroman, 2003) 
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Sexuality is also controlled through systems of gender and class, often functioning as a mirror of wider social attitudes towards difference. This can be shown, for example, through the ableism and heteronormativity that underpin institutions like marriage (although this is now changing in several countries), church, employment and health professions, as several studies from the last decade illustrate (Jackson, 2000; R€ ondahl, Innala, & Carlsson, 2006; Weeks, 2002) .
The depiction of sexuality and cancer as separate facets of identity supports a monodimensional depiction of men with prostate cancer as asexual service users who lack agency. When social behaviours and manifestations of sexuality are controlled by an intricate nexus of expectations and beliefs (such as the availability of medication to allow for erections), sexuality can be understood as a state rather than a possibility, and people who do not fit into this ideal can risk being considered to be asexual (Sakellariou, 2006 (Sakellariou, , 2012 .
However, sexuality in the cancer clinic is, we suggest, a complex mix of personal, social and clinical factors. The evidence would suggest that sexuality is not a topic explored routinely-even in settings where men, who have been diagnosed and treated for prostate cancer, are being reviewed and the impact of their cancer treatment is being followed up (Forbat et al., 2012) .
Male sexuality itself is commonly viewed as phallocentric, reinforcing the centrality of physical performance (Drench, 1992; Shakespeare, 2000) . This can cause feeling of inadequacy and even emasculation to men with prostate cancer. As Shuttleworth, Wedgwood, and Wilson (2012, p. 174) highlight, there is often a perception that "masculinity and disability are in conflict with each other because disability is associated with being dependent and helpless whereas masculinity is associated with being powerful and autonomous." Sexuality, however, is not based only on this mechanistic view of penile strength and function (Milligan & Neufeldt, 2001; Tepper, 2000) , but it can also be understood in terms of emotional closeness and intimate connection. While physical performance is one of the ways through which people can achieve intimacy and sexual pleasure, it can also be achieved through a variety of other, non-performance-based, means.
The problem of introducing discussions about sex into clinical settings is reinforced in several studies including the auto-ethnographic Teratologies, by Stacey (1997) . This provided, amongst many other rich insights into ovarian cancer, a Foucauldian interpretation using narrative and visual constructions of cancer. Both the culture and practice of medicine were altered when it became possible to map the internal body so precisely:
The clinical gaze, which is taken for granted in contemporary Western culture, is not the inevitable outcome of scientific progress or technological invention, but rather originated in a very specific medical culture in which the discourse of visibility became central. The clinic is a place primarily of vision and observation: doctors learn to see, to isolate, to recognise, to compare and thus to match (or not), to scrutinise and then to intervene. (Stacey, 1997, p. 55) In prostate cancer, tumours are scrutinised through a combination of ever more sophisticated technologies such as computerised scans, X-rays, tissue biopsies and blood tests. Novel technologies are emerging constantly which allow images, and radiation therapy, to be panned and rotated in three dimensions similar to what occurs in geophysics and astronomy. Mathematical modelling can also be used to calculate the dosage of radiotherapy required to achieve maximum "cell kill" (Hricack, Choyke, Eberhardt, Leibel, & Scardino, 2007 ).
In such a culture, there is a jarring between the objective/scientific and the emotional/private/sexual self and may go some way to explain the dominance and popularity of heteronormative assumptions. These assumptions may simply feel safer as focusing on the heterosexual majority does not challenge the heteronormative status quo by considering the full range of human sexuality.
| TH E IMPACT OF HETERONORMATIVE INEQUALITY ON PROSTATE CANCER CARE
The Inquiry into Inequalities in Cancer (All Party Parliamentary Group on Cancer's, 2009) reported that in the United Kingdom, gay men have a greater incidence of anal cancer and cancers related to HIV/ AIDS. However, we do not know whether there is also a difference in the incidence of prostate cancer between gay and bisexual men and the general population. Stonewall's survey of the health needs of gay and bisexual men reported that 10% of gay and bisexual men of all ages have discussed prostate cancer with a healthcare provider, while 68% of gay and bisexual men over the age of 50 had not discussed this issue. This is slightly lower compared to men in general (Prostate Cancer UK & Stonewall, 2013, p. 8) .
Gay men have reported that healthcare professionals do not always ask about sexual orientation in initial consultations, making the assumption of heterosexual orientation (Mitteldorf, 2005) . Furthermore, men with prostate cancer have reported not disclosing their sexual orientation to healthcare professionals due to a concern about negative reactions (Filiault, Drummond, & Smith, 2008) or because they think the clinical relevance of their sexual orientation will be disregarded (Katz, 2009) . Recent research in this area has focussed on the impact of prostate cancer on the quality of life of MSM (Lee et al., 2015; Ussher et al., 2016) and is adding to the knowledge base as it allows new evidence to be synthesised as it emerges (Rosser et al., 2016) .
In the most recent Cancer Patient Experience Survey in England, respondents who were identified as MSM reported more negative experiences in relation to communication, respect and dignity in regard to treatment, care and information within the National Health Service (Department of Health, 2012) . A survey on gay and bisexual men's health highlighted that 30% of gay and bisexual men who reported accessing health services in the past year had at least one negative experience related to their sexual orientation (Stonewall, 2013) .
A small online focus group study (Thomas, Wooten, & Robinson, 2013) confirmed the earlier point that emotional reactions to a prostate cancer diagnosis in MSM was associated with requiring access to appropriate information and support. Other factors identified included the role of sexual side effects (such as erectile dysfunction) on their self-identity, a re-evaluation of life generally and the need to find the most suitable health professional who could explore their current and ongoing needs. By doing so, there was agreement that this improved the overall quality of care experience.
| IMPLICATIONS FOR PRACTICE
Cancer not only presents people with issues of finitude, but more importantly, it threatens the very foundation of life's comforting rhythms. Stacey and Bryson (2012) argue that cancer survivorship is comparable with surviving any serious medical trauma, but also, in the case of MSM, from surviving within a normative cancer culture that has yet to accommodate diverse sexualities. Even though normative ideals of masculinity still shape how men understand their health and risks of prostate cancer, the encounter with healthcare professionals needs to accommodate diversity. The findings of Thomas et al. (2013) and Forbat et al. (2012) between different groups of people in terms of incidence, access to services and treatment, patient experience and outcomes (Boehmer, Miao, & Ozonoff, 2011) . We have argued here that LGBT groups may face additional problems as result of heteronormative clinical cultures that fail to appreciate diversity in those accessing their services. It is also important to highlight that the heterosexual majority, gay, bisexual and transgender populations will all face the risk of prostate cancer in the future, making it even more important to allow diversity to be acknowledged and accommodated.
Participatory design approaches of support services for MSM may offer one approach to ensure that personal experience can be used to challenge aspects of services that fail to meet their needs (Al-Itejawi et al., 2015) . Such approaches employ a stepwise approach of feedback on usability at the preconceptual, prototype and usability phase of service design for diverse groups. The challenge facing prostate cancer service researchers is to recruit MSM to such initiatives and to explore their needs in the face of the negative attitudes that may exist in some settings. However, doing so holds the promise of change.
| CONCLUSION
It is important to close the gap in sexuality-based inequalities in cancer treatment. This will require the concerted effort of different stakeholders and organisations. Some of the strategies that are required include learning from prostate cancer patient surveys, networking between cancer and gay organisations to share good practice, learning from people's negative experiences, developing resources for support groups and developing innovative resources (such as training materials) for health professionals to educate them about the importance of diversity awareness in the delivery of supportive prostate cancer care.
A first step in this process is to recognise the negative risks associated with heteronormative attitudes and assumptions and to question the extent to which cancer services may be ignoring the needs of those who do not identify as heterosexual. This paper has proposed that change can best be achieved by drawing on existing evidence, reviewing the experiences of MSM themselves and by making comparisons with other marginalised groups who may also be at risk of inequity during their cancer experience.
| RELEVANCE TO CLINICAL PRACTICE
• Clinical practice is shaped by time pressures and provision of care that is directed towards the majority. These can lead to assumptions about the sexual orientation of cancer patients, including men diagnosed with prostate cancer. When heteronormative assumptions dominate this can lead to embarrassment and inequality in provision of support to MSM.
• Prostate cancer service providers should be aware of the diversity culture that exists in their organisations and monitor the extent to which heteronormative assumptions are acknowledged and challenged.
• To promote diversity and equality in cancer care for all LGBT groups.
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